These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 34751523)

  • 1. Real-time monitoring of drug laboratory test interactions: a proof of concept.
    van Balveren JA; Verboeket-van de Venne WPHG; Doggen CJM; Erdem-Eraslan L; de Graaf AJ; Krabbe JG; Musson REA; Oosterhuis WP; de Rijke YB; van der Sijs H; Tintu AN; Verheul RJ; Hoedemakers RMJ; Kusters R
    Clin Chem Lab Med; 2022 Jan; 60(2):235-242. PubMed ID: 34751523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical usefulness of drug-laboratory test interaction alerts: a multicentre survey.
    van Balveren JA; Verboeket-van de Venne WPHG; Doggen CJM; Cornelissen AS; Erdem-Eraslan L; de Graaf AJ; Krabbe JG; Musson REA; Oosterhuis WP; de Rijke YB; van der Sijs H; Tintu AN; Verheul RJ; Hoedemakers RMJ; Kusters R; ;
    Clin Chem Lab Med; 2021 Jun; 59(7):1239-1245. PubMed ID: 33645171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of interactions between drugs and laboratory test results on diagnostic test interpretation - a systematic review.
    van Balveren JA; Verboeket-van de Venne WPHG; Erdem-Eraslan L; de Graaf AJ; Loot AE; Musson REA; Oosterhuis WP; Schuijt MP; van der Sijs H; Verheul RJ; de Wolf HK; Kusters R; Hoedemakers RMJ;
    Clin Chem Lab Med; 2018 Nov; 56(12):2004-2009. PubMed ID: 30332390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic error as a result of drug-laboratory test interactions.
    van Balveren JA; Verboeket-van de Venne WPHG; Erdem-Eraslan L; de Graaf AJ; Loot AE; Musson REA; Oosterhuis WP; Schuijt MP; van der Sijs H; Verheul RJ; de Wolf HK; Kusters R; Hoedemakers RMJ;
    Diagnosis (Berl); 2019 Mar; 6(1):69-71. PubMed ID: 30753158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical decision support system supported interventions in hospitalized older patients: a matter of natural course and adequate timing.
    Zwietering NA; Linkens A; Kurstjens D; van der Kuy P; van Nie-Visser N; van de Loo B; Hurkens K; Spaetgens B
    BMC Geriatr; 2024 Mar; 24(1):256. PubMed ID: 38486200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physicians' responses to clinical decision support on an intensive care unit--comparison of four different alerting methods.
    Scheepers-Hoeks AM; Grouls RJ; Neef C; Ackerman EW; Korsten EH
    Artif Intell Med; 2013 Sep; 59(1):33-8. PubMed ID: 23746663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Added value of drug-laboratory test interaction alerts in test result authorisation.
    van Balveren JA; Verboeket-van de Venne WPHG; Doggen CJM; Erdem-Eraslan L; de Graaf AJ; Krabbe JG; Musson REA; Oosterhuis WP; de Rijke YB; van der Sijs H; Tintu AN; Verheul RJ; Hoedemakers RMJ; Kusters R
    Clin Chem Lab Med; 2022 Apr; 60(5):e108-e111. PubMed ID: 35184434
    [No Abstract]   [Full Text] [Related]  

  • 8. Implementation of a clinical decision support system for computerized drug prescription entries in a large tertiary care hospital.
    Zenziper Y; Kurnik D; Markovits N; Ziv A; Shamiss A; Halkin H; Loebstein R
    Isr Med Assoc J; 2014 May; 16(5):289-94. PubMed ID: 24979833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature and frequency of drug therapy alerts generated by clinical decision support in community pharmacy.
    Heringa M; Floor-Schreudering A; Tromp PC; de Smet PA; Bouvy ML
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):82-9. PubMed ID: 26602064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Translation of evidence into kidney transplant clinical practice: managing drug-lab interactions by a context-aware clinical decision support system.
    Niazkhani Z; Fereidoni M; Rashidi Khazaee P; Shiva A; Makhdoomi K; Georgiou A; Pirnejad H
    BMC Med Inform Decis Mak; 2020 Aug; 20(1):196. PubMed ID: 32819359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A computerized adverse drug event alerting system using clinical rules: a retrospective and prospective comparison with conventional medication surveillance in the Netherlands.
    Rommers MK; Teepe-Twiss IM; Guchelaar HJ
    Drug Saf; 2011 Mar; 34(3):233-42. PubMed ID: 21332247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems.
    Main C; Moxham T; Wyatt JC; Kay J; Anderson R; Stein K
    Health Technol Assess; 2010 Oct; 14(48):1-227. PubMed ID: 21034668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA-approved drugs that interfere with laboratory tests: A systematic search of US drug labels.
    Yao H; Rayburn ER; Shi Q; Gao L; Hu W; Li H
    Crit Rev Clin Lab Sci; 2017 Jan; 54(1):1-17. PubMed ID: 27193822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring for adverse drug events of high-risk medications with a computerized clinical decision support system: a prospective cohort study.
    Nezu M; Sakuma M; Nakamura T; Sonoyama T; Matsumoto C; Takeuchi J; Ohta Y; Kosaka S; Morimoto T
    Int J Qual Health Care; 2023 Dec; 35(4):. PubMed ID: 37982724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a Standardized Rating Tool for Drug Alerts to Reduce Information Overload.
    Pfistermeister B; Sedlmayr B; Patapovas A; Suttner G; Tektas O; Tarkhov A; Kornhuber J; Fromm MF; Bürkle T; Prokosch HU; Maas R
    Methods Inf Med; 2016 Dec; 55(6):507-515. PubMed ID: 27782288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing Inappropriate Drug Use in Older Patients by Use of Clinical Decision Support in Community Pharmacy: A Mixed-Methods Evaluation.
    Mulder-Wildemors LGM; Heringa M; Floor-Schreudering A; Jansen PAF; Bouvy ML
    Drugs Aging; 2020 Feb; 37(2):115-123. PubMed ID: 31782128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescriber response to computerized drug alerts for electronic prescriptions among hospitalized patients.
    Zenziper Straichman Y; Kurnik D; Matok I; Halkin H; Markovits N; Ziv A; Shamiss A; Loebstein R
    Int J Med Inform; 2017 Nov; 107():70-75. PubMed ID: 29029694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of clinical rules in a standalone pharmacy based clinical decision support system for hospitalized and nursing home patients.
    de Wit HA; Mestres Gonzalvo C; Cardenas J; Derijks HJ; Janknegt R; van der Kuy PH; Winkens B; Schols JM
    Int J Med Inform; 2015 Jun; 84(6):396-405. PubMed ID: 25746461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug interference with biochemical laboratory tests.
    Katanić J; Stanimirov B; Sekeruš V; Đanić M; Pavlović N; Mikov M; Stankov K
    Biochem Med (Zagreb); 2023 Jun; 33(2):020601. PubMed ID: 37143715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventing potential drug-drug interactions through alerting decision support systems: A clinical context based methodology.
    Pirnejad H; Amiri P; Niazkhani Z; Shiva A; Makhdoomi K; Abkhiz S; van der Sijs H; Bal R
    Int J Med Inform; 2019 Jul; 127():18-26. PubMed ID: 31128828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.